FOLH1 and posterior cortical atrophy: PSMA PET has been shown to have higher sensitivity and specificity than conventional imaging for PCa in several clinical settings, from initial staging to detection and localization of biochemical recurrence (BCR), restaging and assessment of eligibility for PSMA-targeted radiopharmaceutical therapies [10].